Rand L - Search Results

1

We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment.

Charlton V, DiStefano M, Mitchell P, Morrell L, Rand L, Badano G, Baker R, Calnan M, Chalkidou K, Culyer A, Howdon D, Hughes D, Lomas J, Max C, McCabe C, O'Mahony JF, Paulden M, Pemberton-Whiteley Z, Rid A, Scuffham P, Sculpher M, Shah K, Weale A, Wester G. Charlton V, et al. Among authors: rand l. Health Econ Policy Law. 2023 Sep 27:1-21. doi: 10.1017/S1744133123000038. Online ahead of print. Health Econ Policy Law. 2023. PMID: 37752732 Free article.

2

An International Review of Health Technology Assessment Approaches to Prescription Drugs and Their Ethical Principles.

Rand LZ, Kesselheim AS. Rand LZ, et al. J Law Med Ethics. 2020 Sep;48(3):583-594. doi: 10.1177/1073110520958885. J Law Med Ethics. 2020. PMID: 33021189 Review.

3

Alternatives to the quality-adjusted life year: How well do they address common criticisms?

Rand LZ, Melendez-Torres GJ, Kesselheim AS. Rand LZ, et al. Health Serv Res. 2023 Apr;58(2):433-444. doi: 10.1111/1475-6773.14116. Epub 2022 Dec 28. Health Serv Res. 2023. PMID: 36537647 Free PMC article.

4

High-Priced Sickle Cell Gene Therapies Threaten to Exacerbate US Health Disparities and Establish New Pricing Precedents for Molecular Medicine.

Tessema FA, Sarpatwari A, Rand LZ, Kesselheim AS. Tessema FA, et al. J Law Med Ethics. 2022;50(2):380-384. doi: 10.1017/jme.2022.66. J Law Med Ethics. 2022. PMID: 35894560

5

Priority-Setting on the Path to Universal Health Care.

Rand LZ. Rand LZ. J Law Med Ethics. 2023;51(1):150-152. doi: 10.1017/jme.2023.51. Epub 2023 May 25. J Law Med Ethics. 2023. PMID: 37226740 Review. No abstract available.

6

International Reference Pricing for Prescription Drugs in the United States: Administrative Limitations and Collateral Effects.

Rand LZ, Kesselheim AS. Rand LZ, et al. Value Health. 2021 Apr;24(4):473-476. doi: 10.1016/j.jval.2020.11.009. Epub 2020 Dec 31. Value Health. 2021. PMID: 33840424 Free article.

7

QALYs In Health Resource Usage Decisions: The Authors Reply.

Rand LZ, Kesselheim AS. Rand LZ, et al. Health Aff (Millwood). 2022 Apr;41(4):610. doi: 10.1377/hlthaff.2022.00197. Health Aff (Millwood). 2022. PMID: 35377767 No abstract available.

8

Trust in the Food and Drug Administration: A National Survey Study.

Feldman WB, Rand LZ, Carpenter D, Russo M, Bhaskar A, Lu Z, Campbell EG, Darrow J, Kesselheim AS. Feldman WB, et al. Among authors: rand lz. Clin Pharmacol Ther. 2024 May 16. doi: 10.1002/cpt.3292. Online ahead of print. Clin Pharmacol Ther. 2024. PMID: 38757305

9

Controversy Over Using Quality-Adjusted Life-Years In Cost-Effectiveness Analyses: A Systematic Literature Review.

Rand LZ, Kesselheim AS. Rand LZ, et al. Health Aff (Millwood). 2021 Sep;40(9):1402-1410. doi: 10.1377/hlthaff.2021.00343. Health Aff (Millwood). 2021. PMID: 34495724

10

International reference pricing for prescription drugs: a landscape analysis.

Rand LZ, Kesselheim AS. Rand LZ, et al. J Manag Care Spec Pharm. 2021 Sep;27(9):1309-1313. doi: 10.18553/jmcp.2021.27.9.1309. J Manag Care Spec Pharm. 2021. PMID: 34464208 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

195 results

Search Page